Cargando…
Height Constitutes an Important Predictor of Mortality in End-Stage Renal Disease
Aim. Height is an important determinant of augmentation index (AI) that anticipates cardiovascular prognosis. There is a scanty of the data whether short height predicts survival in patients with end-stage renal diseases, a high risk population. Methods. Fifty two hypertensive patients with type 2 d...
Autores principales: | Takenaka, Tsuneo, Sato, Takahiko, Hoshi, Hitoshi, Kato, Nobutaka, Sueyoshi, Keita, Tsuda, Masahiro, Watanabe, Yusuke, Takane, Hiroshi, Ohno, Yoichi, Suzuki, Hiromichi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989382/ https://www.ncbi.nlm.nih.gov/pubmed/21113297 http://dx.doi.org/10.4061/2011/242353 |
Ejemplares similares
-
End-stage renal disease (ESRD) contributes to the increasing prevalence of herpes zoster
por: Sato, Takahiko, et al.
Publicado: (2009) -
Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney diseases
por: Takenaka, Tsuneo, et al.
Publicado: (2009) -
Statin Improves Flow-Mediated Vasodilation in Chronic Kidney Diseases
por: Takenaka, Tsuneo, et al.
Publicado: (2013) -
Predictors of long-term prognosis in acute kidney injury survivors who require continuous renal replacement therapy after cardiovascular surgery
por: Sueyoshi, Keita, et al.
Publicado: (2019) -
Antihypertensive medication versus health promotion for improving metabolic syndrome in preventing cardiovascular events: a success rate-oriented simulation study
por: Ohno, Yoichi, et al.
Publicado: (2011)